UBS maintains its Neutral rating on the stock and adjusts its target price to €36.7 (up from €36.5) following the group's announcement of its new strategic plan.

"Ambitious targets, with a strong acceleration in organic growth, margin improvement, and investments in the company. Implementation remains, in our view, essential," UBS states in its report.

Ipsos plans to invest more than one billion euros over the next five years in transformation operations, mainly through acquisitions and strategic investments. This plan will be financed primarily by free cash flow.

The group is targeting an annual organic growth rate of 5% or more by 2028, with an improvement in operating margin expected to reach 13.5%.

At the current share price, the stock is trading at a 2025 P/E ratio of nearly 7 times, with a yield of around 5%.